Advances in Alzheimer's disease's pharmacological treatment

CE Conti Filho, LB Loss… - Frontiers in …, 2023 - frontiersin.org
Alzheimer's disease (AD) is the most common type of dementia in the elderly. Several
hypotheses emerged from AD pathophysiological mechanisms. However, no neuronal …

The amygdala as a locus of pathologic misfolding in neurodegenerative diseases

PT Nelson, EL Abner, E Patel… - … of Neuropathology & …, 2018 - academic.oup.com
Over the course of most common neurodegenerative diseases the amygdala accumulates
pathologically misfolded proteins. Misfolding of 1 protein in aged brains often is …

Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes

L Walker, KE McAleese, AJ Thomas, M Johnson… - Acta …, 2015 - Springer
Multiple different pathological protein aggregates are frequently seen in human postmortem
brains and hence mixed pathology is common. Mixed dementia on the other hand is less …

Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline

DJ Koss, G Jones, A Cranston, H Gardner… - Acta …, 2016 - Springer
Post-mortem investigations of human Alzheimer's disease (AD) have largely failed to
provide unequivocal evidence in support of the original amyloid cascade hypothesis, which …

Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases

G Forloni, V Artuso, P La Vitola… - Movement …, 2016 - Wiley Online Library
The term oligomeropathies defines the neurodegenerative disorders associated with protein
misfolding, where small soluble aggregates (oligomers 4‐200 KDa) are the cause of …

Pyroglutamate and isoaspartate modified amyloid-beta in ageing and Alzheimer's disease

ML Moro, AS Phillips, K Gaimster, C Paul… - Acta neuropathologica …, 2018 - Springer
Alzheimer's disease (AD) is the most common cause of dementia among older adults.
Accumulation of amyloid-β (Aβ) in the brain is considered central in AD pathogenesis and its …

[HTML][HTML] All roads lead to Rome: Different molecular players converge to common toxic pathways in neurodegeneration

S Argueti-Ostrovsky, L Alfahel, J Kahn, A Israelson - Cells, 2021 - mdpi.com
Multiple neurodegenerative diseases (NDDs) such as Alzheimer's disease (AD), Parkinson's
disease (PD), amyotrophic lateral sclerosis (ALS) and Huntington's disease (HD) are being …

[HTML][HTML] Amyloid-β peptide Aβ3pE-42 induces lipid peroxidation, membrane permeabilization, and calcium influx in neurons

AP Gunn, BX Wong, T Johanssen, JC Griffith… - Journal of Biological …, 2016 - Elsevier
Pyroglutamate-modified amyloid-β (pE-Aβ) is a highly neurotoxic amyloid-β (Aβ) isoform and
is enriched in the brains of individuals with Alzheimer disease compared with healthy aged …

Amyloid β modification: a key to the sporadic Alzheimer's disease?

EP Barykin, VA Mitkevich, SA Kozin… - Frontiers in genetics, 2017 - frontiersin.org
Last year marked 25 years of research into the amyloid hypothesis of Alzheimer's disease
(AD)(Selkoe and Hardy, 2016). Over the last few years, studies on this subject have …

High prevalence of focal and multi-focal somatic genetic variants in the human brain

MJ Keogh, W Wei, J Aryaman, L Walker… - Nature …, 2018 - nature.com
Somatic mutations during stem cell division are responsible for several cancers. In principle,
a similar process could occur during the intense cell proliferation accompanying human …